Log in
Enquire now
‌

US Patent 10071988 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10071988
Date of Patent
September 11, 2018
Patent Application Number
15428710
Date Filed
February 9, 2017
Patent Citations Received
‌
US Patent 11447503 Pyridine carbamates and their use as GLUN2B receptor modulators
‌
US Patent RE49517 Pyrazoles
0
‌
US Patent 11759455 Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators
‌
US Patent 11459336 Pyrazine carbamates and their use as GluN2B receptor modulators
‌
US Patent 10233173 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
‌
US Patent 10323021 Triazoles as NR2B receptor inhibitors
‌
US Patent 10377753 Substituted 4-azaindoles and their use as GluN2B receptor modulators
‌
US Patent 11530210 Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators
...
Patent Primary Examiner
‌
Alicia L Otton
Patent abstract

Substituted 1,2,3-triazoles as NR2B receptor ligands. Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10071988 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.